The Global Radioactive Source Market was valued at USD 1070.27 Million in 2023 and is projected to reach USD 1354.24 Million by 2029, exhibiting a Compound Annual Growth Rate (CAGR) of 4.00% during the forecast period (2023–2029). This growth is being driven by rising demand for diagnostic and therapeutic nuclear medicine, expanding non-destructive testing (NDT) applications in industry, and advancements in agricultural irradiation and scientific research.

As the demand for nuclear technologies grows across healthcare, manufacturing, and security sectors, the spotlight is on the key producers and suppliers who ensure the safe and reliable delivery of essential radioisotopes. In this blog, we profile the Top 10 Companies in the Radioactive Source Industry—a group of specialized producers, nuclear research organizations, and global suppliers shaping the future of radiopharmaceuticals and industrial radiation.

---

🔟 1. Curium Pharma

Headquarters: Saint-Louis, Missouri, USA
Key Offering: Mo-99, Tc-99m generators, I-131, Lu-177, Ga-68

Curium Pharma is a global leader in nuclear medicine, providing life-enhancing solutions for diagnostics and therapeutics. The company specializes in a broad portfolio of radioisotopes and radiopharmaceuticals used in millions of patient procedures annually worldwide.

Key Market Initiatives:

• World’s largest producer of Mo-99, the parent isotope for Tc-99m
• Extensive network of cyclotrons and manufacturing facilities
• Focus on targeted radionuclide therapy and diagnostic imaging agents

Download FREE Sample Report: Global Radioactive Source Market – View in Detailed Research Report

---

9️⃣ 2. NRG (Nuclear Research and Consultancy Group)

Headquarters: Petten, Netherlands
Key Offering: Mo-99, medical and industrial isotopes

NRG operates the High Flux Reactor (HFR) in Petten, one of the most powerful multi-purpose research reactors globally and a critical supplier of medical isotopes, particularly Mo-99, to the European and international markets.

Key Market Initiatives:

• Critical supplier to over 30,000 patients daily in Europe
• Pioneering research in nuclear technology and safety
• Development of novel production methods for medical isotopes

---

8️⃣ 3. Nordion (A Sotera Health Company)

Headquarters: Ottawa, Canada
Key Offering: Co-60, Mo-99, Cs-137, Sr-90

Nordion is a leading provider of medical isotopes, gamma technologies, and irradiation services for sterilization and materials modification. The company plays a crucial role in the global supply chain for medical and industrial radioactive sources.

Key Market Initiatives:

• Leading global supplier of Cobalt-60 for medical device sterilization and cancer therapy
• Strategic partnerships with nuclear reactor operators worldwide
• Expanding applications in food safety and pathogen control

---

7️⃣ 4. NTP Radioisotopes SOC Ltd

Headquarters: Pelindaba, South Africa
Key Offering: Mo-99, I-131, Sm-153, Lu-177

NTP Radioisotopes is Africa’s primary producer of radiopharmaceuticals and radioactive sources, operating the SAFARI-1 research reactor. The company serves both domestic healthcare needs and exports globally.

Key Market Initiatives:

• Major supplier of Mo-99 to emerging markets
• Focus on expanding therapeutic radioisotope production
• Development of innovative radiopharmaceuticals for cancer treatment

Download FREE Sample Report: Global Radioactive Source Market – View in Detailed Research Report

---

6️⃣ 5. Eckert & Ziegler Strahlen

Headquarters: Berlin, Germany
Key Offering: Brachytherapy seeds, industrial sources, radiopharmaceuticals

Eckert & Ziegler is a specialist in isotope technology applications for medicine, science, and industry. The company provides a comprehensive range of radioactive sources and components for cancer therapy and industrial measurement systems.

Key Market Initiatives:

• Leading supplier of seeds and sources for brachytherapy
• Advanced manufacturing of sealed radioactive sources
• Global distribution network for medical and industrial isotopes

---

5️⃣ 6. ANSTO (Australian Nuclear Science and Technology Organisation)

Headquarters: Lucas Heights, New South Wales, Australia
Key Offering: Mo-99, Lu-177, I-131, research reactor services

ANSTO operates Australia’s nuclear research facilities, including the OPAL multipurpose reactor, and is the Southern Hemisphere’s leading producer of nuclear medicine. The organization supplies a significant portion of Australia’s medical isotopes and exports internationally.

Key Market Initiatives:

• ANSTO Nuclear Medicine (ANM) produces over 10,000 doses of nuclear medicine weekly
• Pioneering research in cyclotron-produced isotopes
• Expanding production capacity for next-generation therapeutic isotopes

---

4️⃣ 7. China Isotope & Radiation Corporation (CIRC)

Headquarters: Beijing, China
Key Offering: Co-60, Ir-192, I-131, industrial irradiation services

CIRC is China’s largest comprehensive enterprise in the isotope and radiation industry, operating across the entire nuclear technology application chain from isotope production to application development and services.

Key Market Initiatives:

• Dominant position in China’s rapidly growing nuclear medicine market
• Major expansion of irradiation facilities for sterilization and materials processing
• Strategic focus on export markets in Asia and beyond

---

3️⃣ 8. IRE (Institut National des RadioÉléments)

Headquarters: Fleurus, Belgium
Key Offering: Mo-99, I-131, Xe-133, Sm-153

IRE is a Belgian producer of radioisotopes for medical and industrial applications, playing a key role in the European supply chain for diagnostic and therapeutic nuclear medicine.

Key Market Initiatives:

• Production of medical isotopes using cyclotrons and processing facilities
• Development of innovative radiopharmaceuticals for targeted therapy
• Quality assurance and regulatory compliance leadership in Europe

---

2️⃣ 9. Mayak Production Association

Headquarters: Ozersk, Russia
Key Offering: Co-60, Ir-192, Cs-137, industrial isotopes

Mayak is one of Russia’s largest nuclear facilities, involved in radioactive material production, reprocessing, and the manufacturing of sealed sources for industrial and medical applications.

Key Market Initiatives:

• Major supplier of industrial radiography sources for the CIS region
• Production of isotopes for radiation processing and scientific applications
• Technical expertise in handling and processing radioactive materials

---

1️⃣ 10. Board of Radiation and Isotope Technology (BRIT)

Headquarters: Mumbai, India
Key Offering: I-131, P-32, industrial sources, radiopharmaceuticals

BRIT is an Indian government enterprise under the Department of Atomic Energy, focused on the commercialization of indigenous radioisotopes and radiation technology for healthcare and industrial applications.

Key Market Initiatives:

• Key supplier of radiopharmaceuticals to India’s public health system
• Development of cost-effective radiation processing technologies
• Expanding production capabilities to meet growing domestic demand

Get Full Report Here: Global Radioactive Source Market – View in Detailed Research Report

---

🧭 Outlook: The Future of Radioactive Sources Is Targeted and Secure

The radioactive source market is undergoing significant transformation. While traditional isotopes continue to serve critical applications, the industry is increasingly focused on targeted therapeutics, production diversification, and enhanced security protocols to meet evolving global needs.

📈 Key Trends Shaping the Market:

• Shift toward alpha-emitting isotopes for targeted cancer therapy
• Growing emphasis on non-reactor production methods using cyclotrons
• Increasing regulatory focus on source security and lifecycle management
• Expansion of radioisotope applications in environmental monitoring and space exploration

Get Full Report Here: Global Radioactive Source Market – View in Detailed Research Report

The companies listed above are not only supplying essential medical isotopes—they’re advancing the precision medicine revolution and ensuring industrial safety worldwide.